Immunizations

Covid-19: 2 or 3-dose primary series and booster

• 19-26 years

• 27-49 years

• 50-64 years

• 65 years and older

Tags

NGSS.HS-ETS1-3

Doses

• Pneumococcal (PCV15, PCV20, PPSV23)

• All ages:1 or 2 doses depending on indication, see notes for booster recommendations

• Meningococcal A, C, W, Y (MenACWY)

• Ages 19-64 1 dose PCV15 followed by PPSV23 OR 1 dose PCV20

• Meningococcal B (MenB)

• All ages: 2, 3, or 4 doses depending on vaccine or condition

• Hepatitis A (HepA)

• 27 to 45 years : 2 or 3 doses depending on age at initial vaccination or condition

• Human papillomavirus (HPV)

• Ages 19-23: 2 or 3 doses depending on vaccine and indication, see notes for booster recommendations

Zoster recombinant (RZV)

• 19-26 years:

  Not administered

• 27-49 years:

  Not administered

• 50-64 years

  2 doses

• 65 years and older

  2 doses

Varicella (VAR) - of born 1980 or later how many doses for ages 19-64?

(a)  

Measles, mumps, and rubella (MMR) for 19-26 years (a)   ​

• 1 or 2 doses depending on the indication
• 3 doses
• 2 doses for ages 65 and up

Measles, mumps, and rubella (MMR) ​ administered​ (a)   ​

• if born in 1960
• no vaccine
• If born in 1957 or later

Tetanus, diphtheria, pertussis (Tdap or Td) 27-49 y.o.

• 1 dose Tdap, then Td or Tdap booster every 10 years

• 1 dose Tdap each pregnancy; 1 dose Td/Tdap for wound management (see notes)

• 3 dose Tdap each pregnancy; 1 dose Td/Tdap for wound management (see notes)

Influenza live, attenuated (LAIV4)

All Ages

1 dose

(a)  

Influenza Inactivated (IIV4) or Influenza recombinant (RIV4)

• not administered after 64 y.o.

• All ages 1 dose annually

• All ages 2 do3e annually

• All Ages 3 dose annually

COVID-19

All ages

• 2 or 3-dose primary series and booster

• not administered

• 5 doses

• 1 dose annually